Medipharm Labs Corp (LABS) — Cash Flow Reinvestment Rate

Latest as of December 2025: 0.23x

Medipharm Labs Corp (LABS) has a Cash Flow Reinvestment Rate of 0.23x as of December 2025, reinvesting CA$100.00K (capex CA$100.00K ) from operating cash flow of CA$435.00K. See LABS FCF generation index to measure how efficiently the company converts operating cash flow to free cash.

Reinvestment Rate

0.23x
(Capex + Investments) / Operating CF

Total Reinvested

CA$100.00K
Capex + Investments

Operating Cash Flow

CA$435.00K
CAD

Capital Expenditures

CA$100.00K
CAD

Medipharm Labs Corp Cash Flow Reinvestment Rate (2017–2017)

Historical reinvestment intensity for Medipharm Labs Corp across 1 annual periods. For the full cash flow conversion analysis, see cash efficiency ratio of Medipharm Labs Corp.

Annual Cash Flow Reinvestment Rate for Medipharm Labs Corp (2017–2017)

Year-by-year capital reinvestment analysis for Medipharm Labs Corp. See LABS financial flexibility index to measure the company's free cash flow as a share of total liabilities.

Year Reinvestment Rate Total Reinvested (CAD) Operating CF Capex YoY Change
2017 13.22x CA$2.19 Million CA$166.00K CA$2.14 Million
Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow